0.00Open13.30Pre Close0 Volume1 Open Interest63.00Strike Price0.00Turnover1412.07%IV-2.13%PremiumNov 29, 2024Expiry Date14.96Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9874Delta0.0042Gamma4.95Leverage Ratio-6.3963Theta0.0000Rho4.89Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet